18F-DOPA
Sponsors
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Children's Hospital of Philadelphia, Institut Claudius Regaud, University of Alberta
Conditions
ACTHAutonomic FailureBeckwith-Wiedemann SyndromeBrain GliomaBrain TumorCongenital HyperinsulinismCongenital Hyperinsulinism (CHI)Cushing Syndrome
Phase 2
Studies of Elevated Parathyroid Activity
CompletedNCT00001277
Start: 1993-12-15End: 2020-12-23Updated: 2022-06-07
New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
CompletedNCT00001849
Start: 1999-05-20End: 2019-04-26Updated: 2021-04-14
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
RecruitingNCT02019706
Start: 2014-02-12End: 2030-12-31Target: 80Updated: 2026-04-02
Phase 3
Unknown Phase
18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
NCT01916148
Updated: 2025-04-02
Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin
CompletedNCT02856347
Start: 2017-03-22End: 2020-12-20Updated: 2025-11-18
Clinical Laboratory Evaluation of Chronic Autonomic Failure
Active, not recruitingNCT03648905
Start: 2018-09-06End: 2029-12-31Updated: 2026-04-01